• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HER2与ESR2基因多态性和卵巢癌之间的遗传关联:一项荟萃分析。

Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis.

作者信息

Tang Liang, Li Jianming, Bao Meihua, Xiang Ju, Chen Yiwei, Wang Yan

机构信息

Department of Human Anatomy, Histology and Embryology, Institute of Neuroscience, Changsha Medical University, Changsha, People's Republic of China.

Department of Human Anatomy, School of Basic Medical Science, Changsha Medical University, Changsha, People's Republic of China.

出版信息

Onco Targets Ther. 2018 Mar 1;11:1055-1066. doi: 10.2147/OTT.S149428. eCollection 2018.

DOI:10.2147/OTT.S149428
PMID:29535531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5840274/
Abstract

OBJECTIVE

The estrogen receptor (ER) and the human epidermal growth factor receptor 2 (HER2) each play an important role in female cancers. This study aimed to investigate the genetic association between three common single nucleotide polymorphisms (SNPs) and the risk of ovarian cancer. The SNPs investigated in this study were ESR2 rs1271572 and rs3020450 and HER2 rs1801200.

METHODS

In this study, databases were electronically searched in a meta-analysis. Databases used were PubMed, Embase, China National Knowledge Infrastructure (CNKI), Wanfang and Cochrane library. Case-control studies on the association between ESR2 and HER2 polymorphisms were selected according to inclusion and exclusion standard. Articles were evaluated for quality, and data were extracted.

RESULTS

A total of 13 articles with 5,461 cases and 7,603 controls were included in this meta-analysis. The recessive model of ESR2 rs1271572 was shown to be significantly associated with the risk of ovarian cancer ( = 0.008, odds ratio [OR] [95% confidence interval {CI}] = 1.13 [1.03, 1.24]), and this significant association still existed in a subgroup analysis stratified by ethnicity (Asian: = 0.04, OR [95% CI] = 1.92 [1.04, 3.56]; Caucasian: = 0.02, OR [95% CI] = 1.12 [1.02, 1.23]). In addition, the distribution of the dominant model of ESR2 rs3020450 was significantly different in the total group ( = 0.02, OR [95% CI] = 0.71 [0.53, 0.95]) and the Caucasian subgroup ( = 0.02, OR [95% CI] = 0.67 [0.48, 0.94]). Furthermore, no significant association between allelic, dominant, codominant and recessive models of HER2 rs1801200 (V655I) and ovarian cancer was found ( > 0.05).

CONCLUSION

The recessive model of ESR2 rs1271572 and the dominant model of ESR2 rs3020450 might be susceptible factors for ovarian cancer.

摘要

目的

雌激素受体(ER)和人表皮生长因子受体2(HER2)在女性癌症中均发挥重要作用。本研究旨在调查三种常见单核苷酸多态性(SNP)与卵巢癌风险之间的遗传关联。本研究中调查的SNP为ESR2 rs1271572和rs3020450以及HER2 rs1801200。

方法

在本研究中,通过荟萃分析对数据库进行电子检索。使用的数据库有PubMed、Embase、中国知网(CNKI)、万方和考克兰图书馆。根据纳入和排除标准选择关于ESR2和HER2多态性关联的病例对照研究。对文章进行质量评估,并提取数据。

结果

本荟萃分析共纳入13篇文章,包含5461例病例和7603例对照。ESR2 rs1271572的隐性模型显示与卵巢癌风险显著相关(P = 0.008,比值比[OR][95%置信区间{CI}] = 1.13[1.03, 1.24]),并且在按种族分层的亚组分析中这种显著关联仍然存在(亚洲人:P = 0.04,OR[95% CI] = 1.92[1.04, 3.56];高加索人:P = 0.02,OR[95% CI] = 1.12[1.02, 1.23])。此外,ESR2 rs3020450的显性模型在总体组(P = 0.02,OR[95% CI] = 0.71[0.53, 0.95])和高加索亚组(P = 0.02,OR[95% CI] = 0.67[0.48, 0.94])中的分布存在显著差异。此外,未发现HER2 rs1801200(V655I)的等位基因、显性、共显性和隐性模型与卵巢癌之间存在显著关联(P > 0.05)。

结论

ESR2 rs1271572的隐性模型和ESR2 rs3020450的显性模型可能是卵巢癌易患因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/27aafb4c7d44/ott-11-1055Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/f1c1f8b584de/ott-11-1055Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/099ea697b675/ott-11-1055Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/10e55121a0ca/ott-11-1055Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/ecaa1d5f1303/ott-11-1055Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/bd4761d52b92/ott-11-1055Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/27aafb4c7d44/ott-11-1055Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/f1c1f8b584de/ott-11-1055Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/099ea697b675/ott-11-1055Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/10e55121a0ca/ott-11-1055Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/ecaa1d5f1303/ott-11-1055Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/bd4761d52b92/ott-11-1055Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e741/5840274/27aafb4c7d44/ott-11-1055Fig6.jpg

相似文献

1
Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis.HER2与ESR2基因多态性和卵巢癌之间的遗传关联:一项荟萃分析。
Onco Targets Ther. 2018 Mar 1;11:1055-1066. doi: 10.2147/OTT.S149428. eCollection 2018.
2
Evaluation of the epidemiological and prognosis significance of ESR2 rs3020450 polymorphism in ovarian cancer.评估 ESR2 rs3020450 多态性在卵巢癌中的流行病学和预后意义。
Gene. 2019 Aug 20;710:316-323. doi: 10.1016/j.gene.2019.06.017. Epub 2019 Jun 12.
3
Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.雌激素受体β(ESR2)基因的遗传多态性与上皮性卵巢癌风险
Cancer Causes Control. 2009 Feb;20(1):47-55. doi: 10.1007/s10552-008-9216-8. Epub 2008 Aug 15.
4
Association of ESR1 and ESR2 Polymorphisms with Osteoporosis: A Meta-Analysis from 36 Studies.ESR1 和 ESR2 多态性与骨质疏松症的关联:来自 36 项研究的荟萃分析。
J Clin Densitom. 2022 Oct-Dec;25(4):699-711. doi: 10.1016/j.jocd.2022.08.007. Epub 2022 Aug 23.
5
Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study.与三阴性乳腺癌风险改变相关的独特 ESR1 和 ESR2 雌激素受体基因突变:一项病例对照研究。
Gene. 2023 Jan 30;851:146969. doi: 10.1016/j.gene.2022.146969. Epub 2022 Oct 17.
6
Association between melatonin receptor gene polymorphisms and polycystic ovarian syndrome: a systematic review and meta-analysis.褪黑素受体基因多态性与多囊卵巢综合征的相关性:系统评价和荟萃分析。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200824.
7
Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.维生素D受体、雌激素受体1和雌激素受体2基因的遗传多态性可能与帕金森病易感性有关:一项荟萃分析。
Mol Biol Rep. 2014 Jul;41(7):4463-74. doi: 10.1007/s11033-014-3317-0. Epub 2014 Mar 5.
8
The AGT Haplotype of the ESR2 Gene Containing the Polymorphisms rs2077647A, rs4986938G, and rs1256049T Increases the Susceptibility of Unexplained Recurrent Spontaneous Abortion in Women in the Chinese Hui Population.AGT 基因 ESR2 中包含多态性 rs2077647A、rs4986938G 和 rs1256049T 的单倍型增加了中国回族女性不明原因复发性自然流产的易感性。
Med Sci Monit. 2020 May 2;26:e921102. doi: 10.12659/MSM.921102.
9
Association of Estrogen Receptor Genes Polymorphisms With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Based on Observational Studies.基于观察性研究的雌激素受体基因多态性与多囊卵巢综合征相关性的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Oct 4;12:726184. doi: 10.3389/fendo.2021.726184. eCollection 2021.
10
No Association between Estrogen Receptor-Β Rs4986938 and Cancer Risk: A Systematic Review and Meta-Analysis.雌激素受体-β Rs4986938与癌症风险之间无关联:一项系统评价与Meta分析
Iran J Public Health. 2019 May;48(5):784-795.

引用本文的文献

1
Efficacy and safety of Shenfu injection on bradyarrhythmia: A systematic review and meta-analysis.参附注射液治疗缓慢性心律失常的疗效与安全性:一项系统评价和Meta分析
Medicine (Baltimore). 2025 May 2;104(18):e41779. doi: 10.1097/MD.0000000000041779.
2
Causal associations of self-reported walking pace with respiratory diseases: A Mendelian randomization analysis.自我报告的步行速度与呼吸系统疾病的因果关联:一项孟德尔随机化分析。
Medicine (Baltimore). 2025 Mar 14;104(11):e41746. doi: 10.1097/MD.0000000000041746.
3
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance.

本文引用的文献

1
Laparoscopically Assisted Anorectal Pull-Through versus Posterior Sagittal Anorectoplasty for High and Intermediate Anorectal Malformations: A Systematic Review and Meta-Analysis.腹腔镜辅助肛门直肠拖出术与后矢状位肛门直肠成形术治疗中高位肛门直肠畸形的系统评价和Meta分析
PLoS One. 2017 Jan 18;12(1):e0170421. doi: 10.1371/journal.pone.0170421. eCollection 2017.
2
Association of HER2 codon 655 polymorphism with ovarian cancer.人表皮生长因子受体2(HER2)第655密码子多态性与卵巢癌的关联
Tumour Biol. 2016 Jun;37(6):7239-44. doi: 10.1007/s13277-015-4609-2. Epub 2015 Dec 14.
3
Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.
IFNγ诱导的卵巢癌中Bcl3、PD-L1和IL-8信号传导:机制与临床意义
Cancers (Basel). 2024 Jul 27;16(15):2676. doi: 10.3390/cancers16152676.
4
Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer.没食子酸表没食子儿茶素酯和姜黄素抑制 Bcl-2:一种基于药效团和对接的抗癌方法。
Breast Cancer Res. 2024 Jul 8;26(1):114. doi: 10.1186/s13058-024-01868-9.
5
Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis.采用孟德尔随机化分析揭示代谢因素与卵巢癌风险之间的因果关联。
Front Endocrinol (Lausanne). 2024 Jun 5;15:1401648. doi: 10.3389/fendo.2024.1401648. eCollection 2024.
6
The IL-12 family of heterodimeric cytokines in polycystic ovarian syndrome: biological role in induction, regulation, and treatment.白细胞介素-12 家族在多囊卵巢综合征中的作用:诱导、调节和治疗中的生物学作用。
Immunol Res. 2024 Aug;72(4):583-591. doi: 10.1007/s12026-024-09487-4. Epub 2024 May 21.
7
Advancing forensic-based investigation incorporating slime mould search for gene selection of high-dimensional genetic data.推进基于法医学的调查,纳入黏菌搜索,以选择高维遗传数据的基因。
Sci Rep. 2024 Apr 13;14(1):8599. doi: 10.1038/s41598-024-59064-w.
8
Diabetes and diabetic associative diseases: An overview of epigenetic regulations of TUG1.糖尿病及糖尿病相关疾病:TUG1的表观遗传调控概述
Saudi J Biol Sci. 2024 May;31(5):103976. doi: 10.1016/j.sjbs.2024.103976. Epub 2024 Mar 11.
9
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis.乳腺癌骨转移建模及药物筛选系统的发展趋势
J Biol Eng. 2024 Feb 5;18(1):14. doi: 10.1186/s13036-024-00408-5.
10
Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility.高胰岛素血症通过AKT-NR4A1信号通路损害蜕膜化:对多囊卵巢综合征(PCOS)相关不孕症的新见解。
J Ovarian Res. 2024 Feb 3;17(1):31. doi: 10.1186/s13048-023-01334-8.
雌激素受体2(ESR2)基因启动子区域多态性与卵巢癌易感性
Gene. 2014 Aug 10;546(2):283-7. doi: 10.1016/j.gene.2014.05.066. Epub 2014 Jun 2.
4
Polymorphism and overexpression of HER2/neu among ovarian carcinoma women from Tiruchirapalli, Tamil Nadu, India.印度泰米尔纳德邦蒂鲁吉拉伯利的卵巢癌患者中 HER2/neu 的多态性和过表达。
Arch Gynecol Obstet. 2013 Dec;288(6):1385-90. doi: 10.1007/s00404-013-2892-y. Epub 2013 May 31.
5
HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.卵巢癌患者中HER2基因第655位密码子异亮氨酸突变为缬氨酸的单核苷酸多态性
Iran Red Crescent Med J. 2013 Jan;15(1):1-3. doi: 10.5812/ircmj.2173. Epub 2013 Jan 5.
6
Role of estrogen receptor β in gynecological cancer.雌激素受体β在妇科癌症中的作用。
Gynecol Oncol. 2012 Dec;127(3):673-6. doi: 10.1016/j.ygyno.2012.09.006. Epub 2012 Sep 11.
7
ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective.表皮生长因子受体家族抑制剂在乳腺癌中的治疗作用:现状和未来临床展望。
Med Res Rev. 2012 Jan;32(1):166-215. doi: 10.1002/med.20209. Epub 2010 Oct 25.
8
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.雌激素受体β rs1271572 多态性与侵袭性卵巢癌风险:卵巢癌协会联盟内的汇总分析。
PLoS One. 2011;6(6):e20703. doi: 10.1371/journal.pone.0020703. Epub 2011 Jun 6.
9
Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.HER2 I655V 多态性与乳腺癌风险之间关联的缺乏复制:系统评价和荟萃分析。
Cancer Epidemiol. 2011 Dec;35(6):503-9. doi: 10.1016/j.canep.2011.01.007. Epub 2011 Apr 7.
10
HER2 status and breast cancer therapy: recent advances.人表皮生长因子受体2(HER2)状态与乳腺癌治疗:最新进展
F1000 Med Rep. 2009 Mar 17;1:20. doi: 10.3410/M1-20.